PARADIGM BIOPHARMACEUTICALS (PBIGF:OTCMKTS)
$0.18 0.0154 (9.356%)
Analysed PARADIGM BIOPHARMACEUTICALS (PBIGF:OTCMKTS) News Sources
Could Paradigm Biopharmaceuticals’ (ASX:PAR) Leadership Presence Signal a Shift in Its Growth Story?
26-10-2025
yahoo.com
Paradigm Biopharmaceuticals (ASX:PAR): Exploring Valuation as Leadership Prepares for Ignite Investment Summit Presentation
25-10-2025
yahoo.com
Weekly Picks: 🇺🇸 A Hedge Against US Government Shutdown And 2 More Picks
21-10-2025
yahoo.com
Paradigm Biopharmaceuticals Limited's (ASX:PAR) Profit Outlook
02-10-2025
yahoo.com
What is the current price of PARADIGM BIOPHARMACEUTICALS (PBIGF:OTCMKTS)?
The current price of PARADIGM BIOPHARMACEUTICALS (PBIGF:OTCMKTS) is $0.18.
PARADIGM BIOPHARMACEUTICALS (PBIGF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of PARADIGM BIOPHARMACEUTICALS (PBIGF:OTCMKTS) since the previous trading day is $0.0154.
PARADIGM BIOPHARMACEUTICALS (PBIGF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of PARADIGM BIOPHARMACEUTICALS (PBIGF:OTCMKTS) since the previous trading day is 9.356%.
What is the most recent average sentiment score for PARADIGM BIOPHARMACEUTICALS (PBIGF:OTCMKTS)?
The most recent average sentiment score for PARADIGM BIOPHARMACEUTICALS (PBIGF:OTCMKTS) is 82 out of 100.
What is the most recent average sentiment for PARADIGM BIOPHARMACEUTICALS (PBIGF:OTCMKTS)?
The most recent sentiment for PARADIGM BIOPHARMACEUTICALS (PBIGF:OTCMKTS) is .
SEC-8K** Filing Available For PARADIGM BIOPHARMACEUTICALS (PBIGF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.